Tag: firstCrew

Anne has been Managing Partner of MC Services since 2011 and has over 25 years of experience in Financial and Strategic Communications. She was instrumental in growing MC Services to a team of 40 people and a highly sustainable client roster. Anne established the office in Düsseldorf, building the team and operations there. Prior to joining the agency, she held senior management positions in international pharma and biotech companies. She headed Investor Relations and Corporate Communications at Evotec AG for 10 years and was a member of the company’s Executive Committee. During that time, she managed Evotec’s IPO on the Frankfurt Stock Exchange and Nasdaq, multiple M&A programs and major financial transactions. Previously, she was responsible for Investor Relations and Corporate Communications at Schwarz Pharma AG, where she initially held management positions in the International Marketing department. Anne is a pharmacist and marketing expert by training.

Raimund founded MC Services in 1999. Under his leadership, MC Services has grown to a team of 40 people with sites in Munich, Düsseldorf, Berlin, London and Boston. Prior to that, Raimund held senior management positions in international communications agencies where he was responsible for Business to Business, Corporate and Financial Communications. He has over 40 years of experience in Marketing and Communications and more than 20 years in Investor Relations. He has advised on IPOs in Germany, Belgium and the UK as well as on major international M&A and financial transactions. Raimund also advises companies on issues and crisis management. Raimund studied law, history and political science (MA).

Katja joined MC Services in 2013, became a partner in 2014 and has been Managing Director of the Munich office since 2016. She was appointed as a member of the Management Board in 2024. She is a Certified Investor Relations Officer (CIRO) and an expert in strategic, financial and corporate communications.

Katja has worked for over 25 years for companies in the biotechnology, medical technology, diagnostics and healthcare sectors as well as for venture capital firms. She has broad in-house expertise in various listed companies and many years of consulting experience. Katja has provided communications support for a large number of corporate financings, M&A transactions, license agreements and all phases of biopharmaceutical product development and market launches. Her work also focuses on C-level and corporate positioning, leadership changes and crisis communications. Katja has developed a strong team in Munich with whom she provides strategic consultancy to many long-standing clients, including Nasdaq and Euronext listed companies. She studied Business Administration at the Technical University of Dresden and has worked for the German Privatization Agency (Treuhandanstalt), Marseille Kliniken, CAT Consultants (currently Silvester Group), Zapf Creation and WILEX (currently Heidelberg Pharma)